Patient perspectives of successful adalimumab biosimilar transitioning in Crohn's disease: an interview study.

David Young J R Fraser Cummings Susan Latter

Published in: European journal of hospital pharmacy : science and practice (2022)

The majority of patients felt comfortable with future transition to another adalimumab biosimilar. Injection experience was an important component of patient satisfaction.

Keyphrases

patient satisfaction
end stage renal disease
rheumatoid arthritis
ejection fraction
newly diagnosed
chronic kidney disease
juvenile idiopathic arthritis
peritoneal dialysis
prognostic factors
case report
ulcerative colitis
patient reported outcomes